Picture of Taisho Pharmaceutical Holdings Co logo

4581 — Taisho Pharmaceutical Holdings Co News Story

0.000.00%
jp flag iconLast trade - 00:00
HealthcareBalancedLarge CapHigh Flyer

Table: Taisho Pharmaceutical HD - 9-MTH group results

Feb 13 (Reuters)- 
             Taisho Pharmaceutical Holdings Co Ltd 
             CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                   9 months ended      9 months ended       Year to 
                  Dec 31, 2023        Dec 31, 2022     Mar 31, 2024 
                     LATEST             YEAR-AGO          LATEST    
                     RESULTS             RESULTS         FORECAST   
  Sales              246.67              227.67                     
                   (+8.3 pct)          (+13.8 pct)                  
  Operating           19.02               23.12                     
                   (-17.8 pct)        (+224.2 pct)                  
  Recurring           23.72               29.17                     
                   (-18.7 pct)        (+153.8 pct)                  
  Net                 10.32               20.90                     
                   (-50.6 pct)        (+132.9 pct)                  
  EPS              125.93 yen          254.93 yen                   
  EPS Diluted      125.75 yen          254.60 yen                   
  Ann Div                              100.00 yen        50.00 yen  
  -Q2 div           50.00 yen           50.00 yen                   
  -Q4 div                               50.00 yen           NIL     
  
  NOTE - Taisho Pharmaceutical Holdings Co Ltd. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4581.T

Recent news on Taisho Pharmaceutical Holdings Co

See all news